Globes — French pharmaceutical company Sanofi has announced that it is entering the “beyond drug” sector – support for drug prescriptions with a digital envelope. Its partner will be Happify Health, founded by Israelis in the US.
The first products are designed to treat patients suffering from depression and multiple sclerosis patients. The idea is for these products to be approved for marketing as drugs after undergoing clinical trials in combination with the drug and the ability of the applications to improve the situation of the patients is proven.
May 15, 2019 – The DCRI will bring its regulatory experience and clinical expertise to the conversation surrounding digital therapeutics.
The DCRI has joined a new alliance focused on bringing digital therapeutics solutions to patients.
The Digital Therapeutics Alliance (DTA), formed in 2017, works to improve access to digital therapeutics for patients, providers, and payers, in an effort to reduce costs and enhance individualized health care. The DTA currently has 25 members, and the DCRI is the first academic member.
“The DTA seeks to broaden the global digital therapeutics conversation within their organization, and the DCRI brings a different perspective,” said the DCRI’s Scott Kollins, PhD (pictured top), who helped lead the DCRI’s application process to join the alliance. “This is a good way for to us to continue and amplify our work in digital therapeutics and potentially become leaders in the space.”
SEVEN HILLS, Ohio–(BUSINESS WIRE)–Anthem Blue Cross and Blue Shield in Ohio (Anthem) today announced the rollout of an innovative new program, with Propeller Health’s collaboration, to help improve health outcomes for Ohio consumers enrolled in Anthem’s Medicare Advantage health plans who have chronic obstructive pulmonary disease (COPD).
“This collaboration between Anthem and Propeller gives individuals access to connected care technology that will help them more easily manage their COPD, in order to help them have a better quality of life. Anthem will continue to focus on improving consumers’ healthcare experience by increasing access to high-quality, meaningful solutions.”
SAN FRANCISCO, May 20, 2019 (GLOBE NEWSWIRE) — Big Health, a digital therapeutics company dedicated to helping millions back to good mental health, today announced over 12 million people now have access to their flagship product, Sleepio.
Thanks to a partnership with the UK’s National Health Service (NHS), 8 million Londoners and 2.3 million in the Thames Valley now have free access to Sleepio, an evidence-based digital therapeutic for poor sleep. Combined with another 2 million covered employees at Big Health employer customers in the United States, Big Health’s total covered population amounts to over 12 million individuals.
Big Health, a digital therapeutics company dedicated to helping millions back to good mental health, today announced over 12 million people now have access to their flagship product, Sleepio.
Thanks to a partnership with the UK’s National Health Service (NHS), 8 million Londoners and 2.3 million in the Thames Valley now have free access to Sleepio, an evidence-based digital therapeutic for poor sleep. Combined with another 2 million covered employees at Big Health employer customers in the United States, Big Health’s total covered population amounts to over 12 million individuals.
Milwaukee, WI and Columbia, MD – May 14, 2019 – The Business Health Care Group (BHCG), a coalition of employers located throughout eastern Wisconsin, recently announced a partnership with Welldoc, a leading digital therapeutic company working with individuals with chronic diseases. The company will offer its award-winning digital assistant BlueStar program to BHCG member employers at preferred rates. BlueStar is a web and mobile in-app coach designed to engage people with type 2 diabetes. It delivers precision-based real-time feedback, diabetes educational tools, and provides actionable insights to the user’s care team to optimize care.
The program is available to employers and their plan participants, both locally and nationally (including outside of the BHCG 22-county Wisconsin region), either through full BHCG membership or on a stand-alone basis.
Recorded live from the MM&M Transforming Healthcare conference at the Edison Ballroom in midtown Manhattan, this episode of the podcast features Megan Coder, executive director of the Digital Therapeutics Alliance. She and MM&M’s executive editor Marc Iskowitz talk about the leading firms in digital therapeutics, what the relationship is between DTx firms and pharma/payers and how those in the discipline are using real world evidence studies to prove their value.
WASHINGTON and CAESAREA, Israel, April 30, 2019 /PRNewswire/ — Global digital therapeutics innovator, DarioHealth Corp. (NASDAQ: DRIO), today announced that it is now a member of the Digital Therapeutics Alliance (DTA) (www.DTxAlliance.org).
Dario’s acceptance to the DTA as a new member demonstrates its commitment to the core principles of the DTA – encouraging data-driven integration and utilization of digital therapeutics across the healthcare industry, engaging patients and enabling healthcare providers to intelligently manage and expand the delivery and quality of patient care, optimizing clinical treatment pathways, enhancing patient outcomes, increasing overall healthcare value and educating patients, providers, payers, and other healthcare industry stakeholders, on the value and improved health outcomes delivered through digital therapeutics.
U.S. Senate — Implementing the 21st Century Cures Act: Making Electronic Health Information Available to Patients and Providers
The U. S. Senate Committee on Health, Education, Labor and Pensions hosts a committee hearing on health data privacy, interoperability, and patient and provider access to electronic health information. An archive of the hearing and related published testimony is available.
Participants in this hearing include:
This month, we are thrilled to welcome the following companies as DTA members:
We appreciate developing such a strong diversity of perspectives across our membership and we look forward to working with each of your teams in the coming year. Welcome aboard!
DTA continues to welcome new members. If you are interested in submitting your DTx company, health system, academic medical center, investment firm, or patient advocacy organization for membership consideration, please visit the DTA membership application.